Evidence Hub

P02.82. Correction of the Omega-3 Index in women with metabolic syndrome by adding omega-3 supplements to a Mediterranean-style diet

R. Lerman, K. Browning, L. Kaskel, M. McIntosh, W. Najm, Maria Luz Fernandez, E. Baruffi, W. Harris

BMC Complementary and Alternative Medicine, 2012

56 participants · 4 citations

Abstract

Methods One trial and one case series are reported here. The trial was a 12-week multicenter study (N=56) testing the effects of MLG diet on the O3I, and the case series was conducted in the offices of two physicians and included 21 women who were given, in addition to a MLG diet recommendation, one of two omega-3 supplements for approximately 12 weeks. One supplement (N=12) provided 1980 mg EPA+DHA per day (High DHA, Metagenics Inc.), and the other supplement (N=9) provided 2880 mg EPA+DHA daily (EPA-DHA 720, Metagenics Inc.). RBC fatty acid profiles were determined by gas chromatography and CVD risk factors by standard laboratory methods.

How strong is the evidence?

Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health. Reported size: 56 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free